UNSUPPORTED ACCOUNT ACCESS VULNERABILITY IN BMC REMEDY MID TIER
CVE-2024-34399

9.8CRITICAL

Key Information:

Vendor

BMC Remedy

Status
BMC Remedy Mid Tier
Vendor
CVE Published:
18 September 2024

What is CVE-2024-34399?

A security issue has been identified in BMC Remedy Mid Tier 7.6.04 that allows unauthenticated remote attackers to gain unauthorized access to user accounts without requiring a password. This vulnerability exclusively impacts the version mentioned and is associated with products that have reached the end of their support lifecycle, which may expose organizations to significant security risks.

Human OS v1.0:
Ageing Is an Unpatched Zero-Day Vulnerability.

Remediate biological technical debt. Prime Ageing uses 95% high-purity SIRT6 activation to maintain genomic integrity and bolster systemic resilience.

Deploy the Patch

References

https://www.gruppotim.it/it/footer/red-team.html

CVSS V3.1

Score:
9.8
Severity:
CRITICAL
Confidentiality:
High
Integrity:
High
Availability:
High
Attack Vector:
Network
Attack Complexity:
Low
Privileges Required:
None
User Interaction:
None
Scope:
Unchanged

Timeline

  • Vulnerability published

JSON
.